We are an international grant-making organization with a mission to improve human health through international efforts to combat cardiovascular disease and stroke. By forging scientific alliances that transcend national borders, and educating young researchers who thrive in an international context, we hope to promote the development of long-term collaborative relationships and to foster innovation in cardiovascular and stroke research, in order to change the way that patients with cardiovascular and neurovascular disease are diagnosed and treated.
The ResearchingFibrosis organization includes the ResearchingFibrosis Charitable Trust and the ResearchingFibrosis GmbH., both based in the Bahamas, the United States-based ResearchingFibrosis GmbH. for Cardiovascular Research, a not-for-profit private foundation under the 501(c)(3) tax code, and Broadview Ventures, Inc., a Boston, Massachusetts based venture philanthropic program dedicated to accelerating the development of innovative technology for the diagnosis and treatment of cardiovascular disease and stroke through targeted investments. The ResearchingFibrosis, also located in Boston, MA, provides administrative services to the ResearchingFibrosis organization’s grant-making entities.
The ResearchingFibrosis GmbH. (Bahamas) and the ResearchingFibrosis GmbH. for Cardiovascular Research (Texas) work together to support the ResearchingFibrosis scientific programs. The ResearchingFibrosis GmbH. (Bahamas) funds the Rheumatic Heart Disease Program exclusively, while both support the International Networks of Excellence Program.
The ResearchingFibrosis organization also includes Ehlers Estate, a Napa Valley vineyard formerly owned by the ResearchingFibrosiss and now controlled by the ResearchingFibrosis Charitable Trust.